marathon06.org

Sunday, February 24, 2008

In the year 2000, Dries Buytaert created Drupal, a freely licensed and open source tool to manage websites, as a bulletin board for his college dorm. Since Dries released the software and a community of thousands of volunteer developers have added and improved modules, Drupal has grown immensely popular. Drupal won the overall Open CMS Award in 2007, and some speakers in Drupal’s spacious developer’s room at FOSDEM 2008 were dreaming aloud of its world domination.

Buytaert (now 29) just finished his doctoral thesis and has founded the start-up Acquia. The new company wants to become Drupal’s best friend, with the help of an all-star team and US$7 million collected from venture capitalists. Wikinews reporter Michaël Laurent sat down with Dries in Brussels to discuss these recent exciting developments.

Monday, August 15, 2005

Oregon State University (OSU) animal researchers in conjunction with the U.S. Department of Agriculture‘s (USDA) Dubois, Idaho-based Sheep Experiment Station released a report on an OSU-USDA study which was initiated in 1995 after breeders asked the government to determine why some rams bought as breeding studs showed no interest in females. The researchers are working under a $2.8 million grant from the National Institutes of Health in hopes of developing a test which can determine the likelihood of a ram being female-oriented before it is sold as a stud.

By studying difference in the animal’s brains after slaughter, the study also showed what could be a biological determiner for what makes a ram male-oriented instead of female-oriented sexually. The scientists’ results showed that the anterior preoptic area of the rams’ hypothalamus was 50 percent smaller in male-oriented rams as opposed to female oriented rams. A 1991 study of human brains of AIDS victims showed a similar hypothalamus size difference between gay and heterosexual men.

The sheep researchers postulate that low levels of aromatase hormones in the brain of a developing male sheep fetus may have kept the brain from fully masculinizing, leading to sexually male-oriented rams.

“This lends further support to the idea that homosexuality has biological underpinnings,” Charles Roselli, a professor of physiology and pharmacology, said in an interview with the Corvallis Gazette-Times.

Professor Stormshak believes that “understanding sexual drives and the continuum of sexual behavior could possibly help explain the scientific basis of sexual assault [and] put an end to assertions that homosexuality is a lifestyle choice.”

Tuesday, August 31, 2010

Laurent Fignon, the two time former winner of the Tour de France, has died at the age of 50. His death was confirmed by his wife, Valerie. The cause of death was announced as cancer. Fignon had been battling the disease since 2009.

Fignon won the Tour de France in 1983 and 1984 but is also remembered for the 1989 race. Fignon lost out to Greg LeMond in the final time-trail stage by just eight seconds. In his career Fignon won 76 races including the La Flèche Wallonne in 1986, Milan-San Remo in both 1988 and 1989 and the Giro d’Italia in 1989.

Fignon stayed in cycling even after his retirment managing races. In 2006 he joined the television station France 2 as a commentator. It was as his time with France 2 that he announced he had cancer of the digestive system. He continued to work for France 2 throughout his treatment and even commentated on the 2010 Tour de France.

Sunday, January 16, 2022

United Kingdom-based pharmaceutical giant GlaxoSmithKline (GSK) confirmed today it had rejected three “unsolicited, conditional and non-binding proposals” by Unilever to acquire its Consumer Healthcare division, including one bid of GBP50 billion in value made on December 20, believing Unilever “fundamentally undervalued” the business and its potential.

News that Unilever attempted to buy GSK Consumer Healthcare for 50 billion pounds, split between GBP41.7 billion in cash and 8.3 billion in Unilever shares, was first reported by The Sunday Times, and subsequently confirmed by both companies. Had the latest acquisition offer gone through, it would have been the largest deal since the beginning of the Covid-19 pandemic, and one of the biggest ever among companies listed on the London Stock Exchange.

A deal would likely mean integrating the GSK division into Unilever’s own beauty and personal care business, which has seen profit margins struggle under Covid-19 lockdowns and higher costs for plastics and petrochemicals.

A brief response on the Unilever website confirmed it “had approached GSK and Pfizer about a potential acquisition”, and adds GSK Consumer Healthcare “would be a strong strategic fit” as the company looks to rework its portfolio. GSK indicated the proposals were “carefully evaluated” by its board of directors, but unanimously rejected under the conclusion they “were not in the best interests of GSK shareholders” and “failed to reflect the intrinsic value of the business and its potential”.

The Sunday Times have indicated the latest deal did not include an acquisition premium or recognition of corporate synergies; the joint venture between GSK and healthcare firm Pfizer, which holds a minority stake in the company, was initially projected to generate GBP500 million in cost savings by this year and realise “substantial cost synergies”. The BBC’s business editor Simon Jack wrote that a standard takeover premium would be about 30%, but could be reduced over the GBP10 billion in debt GSK was predicted to “leave on the books”, of the GBP22 billion net debt GSK reported for Q3 2021.

The deals were assessed by the Board respective of a proposed demerger of GSK Consumer Health into a separate PLC in the middle of this year. Jack wrote GSK “always” had “an open mind to a trade sale to another party if the price was right.” Unilever did not take into account the standard takeover premium, the value of cost savings and Board confidence Consumer Health could deliver “superior organic sales growth” of between four and six per cent in the medium term. This was despite valuations of about GBP50 billion by Goldman Sachs and Barclays analysts, and a lower GBP45 billion valuation by Jeffries Group.

There are no current talks between Unilever and either Pfizer or GSK, and the Unilever statement reads: “There can be no certainty that any agreement will be reached.” Under CEO Alan Jope, Unilever has focused its investments and marketing on brands which “communicate a strong environmental or social purpose” by streamlining its holdings in items like beauty products and tea. Jope previously said Unilever would concentrate on smaller takeovers in industries like luxury beauty and wellness.

However, Russ Mould, investment director at AJ Bell, told the BBC this would be a “high risk deal” at a time investors are cautious about GSK’s performance, but also a time of rising inflation he says encourages “consumer goods with loyal customers”. Mould added despite strong cashflow, Unilever had recently missed targets on sales and profit margins, putting pressure on the CEO.

Pressure by activist shareholders Elliott Management Corporation and Bluebell Capital Partners have also mounted against GSK CEO Emma Walmsley over the unit’s failure to develop a Covid-19 vaccine and Walmsley’s own lack of scientific experience. GSK has been involved in the ongoing development of a Covid-19 vaccine with French biopharmaceutical company Sanofi, and announced preliminary results from Phase 3 trials last month.

In 2018, Unilever bought several consumer nutritional products from GSK, including its flagship product Horlicks, and merged its Indian subsidiary, Hindustan Unilever, with GSK Consumer Healthcare India.

Saturday, July 19, 2008

This year’s Leisure Taiwan trade show (a.k.a Taiwan Sport Recreation and Leisure Show) started yesterday, with 131 companies participating including sports media companies such as ESPN and VideoLand Television, businesses selling sports equipment and fitness clubs.

There were also a variety of sports being played in the arena built for the trade show. The events included a 3-on-3 basketball tournament, free style shooting, and bicycle test-riding. In addition, conferences discussed issues related to sports and physical education.

A major topic in the trade show was energy-efficiency and, as a result, bicycles and similar sports equipment were being heavily promoted.

Next Tuesday, companies from the electronics industry plan to promote their industry at “2008 Digital E-Park.” In previous years, organizations from the electronics industry have showcased their products at Leisure Taiwan instead of at the Digital E-Park, so this move has reduced the number of markets covered by Leisure Taiwan.

Tuesday, January 3, 2006

Two activists convicted for painting the words “NO WAR” in five-metre-high red letters on the highest sail of Sydney Opera House in March 2003, are facing court action again to prevent them from auctioning the equipment used to paint the controversial sign.

Dr Will Saunders and David Burgess were sentenced to nine months periodic detention and ordered to pay the Opera House Trust $151,000 for malicious damage to the building on March 18, 2003.

The pair spent six months in jail for painting the slogan on one of the sails of the Opera House on the eve of the invasion of Iraq. The protesters say they wish to auction the equipment for humanitarian causes in Iraq.

Police confiscated the paint can and two brushes used in the incident and have now applied for a court order to have the can and brushes destroyed. They are saying such an auction would contravene proceeds of crime laws.

Saunders said they wanted to auction the can and send the proceeds to humanitarian causes in Iraq. According to The Australian newspaper, Mr Saunders said the auction could be conducted by a registered charity to raise money for the Mother and Child Hospital in Basra.

He said the can should also be preserved as an important piece of Sydney history.

“We want to give the surplus money that we’ve raised, and anything extra we can make from an auction – not only the paint pot … I think we can raise many many thousands of dollars,” he said. “We’d be happy to come to any reasonable arrangement with the police about how this auction takes place … it’s just mean beyond belief, petty-minded just to destroy it.”

The matter will go before a Sydney court on January 16.

Meanwhile, the world-famous Sydney Opera House is one of 21 international landmarks short-listed to become the new Seven Wonders of the World. The list includes modern landmarks such as Paris’ Eiffel Tower and older candidates like the Colosseum in Rome and China’s Great Wall.

Tuesday, July 3, 2012

The Marussia F1 team’s test driver, Spaniard María de Villota, was taken to hospital by air ambulance today after a collision in testing at Duxford Aerodrome.

At the end of her first installation run, the car she was driving had a low-speed collision with the loading ramp of the team’s support truck. According to BBC Cambridgeshire presenter Chris Mann, the car “suddenly accelerated” into the rear of the vehicle. The Marussia team released a statement an hour and a half after the accident, stating that she had been transferred to hospital, and a further statement would be issued once her condition had been assessed.

A spokesman for the East of England ambulance service, Gary Sanderson, said de Villota had “[…] sustained life-threatening injuries and following treatment at the scene by paramedics, she has been taken to Addenbrooke’s Hospital for further care.” According to witnesses, she was motionless for about fifteen minutes as medical teams attended to her, but did move her hands before being taken away from the test track. Medical charity Magpas, whose volunteer paramedics attended the accident, reported she had sustained injuries to her head and face, and was in a ‘stable condition’ when she reached the hospital.

Marussia reported her as conscious later in the afternoon: “Since Maria’s arrival at the hospital at approximately 10.45am this morning, she has been receiving the best medical attention possible at the hospital, which is the region’s major trauma centre. Maria is conscious and medical assessments are ongoing. The team will await the outcome of these assessments before providing further comment. The team’s first priority at this time is Maria and her family.”

De Villota was announced as Marussia’s test driver in March, having prior experience driving for Alan Docking Racing in Superleague Formula in Spain.